Jacob Gary S
- SEC CIK
- 0001266802
In the past year, 1 open-market purchase filing worth $4.90K and no sales.
Current role at each company
- OKYO OKYO Pharma LtdCHIEF DEVELOPMENT OFFICERas of Aug 7, 2026
- HEPA Hepion Pharmaceuticals, Inc.Directoras of Feb 21, 2024
- VRPX Virpax Pharmaceuticals, Inc.Directoras of Jan 5, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $4.90K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$4.90K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Jacob Gary S as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
OKYO OKYO Pharma Ltd
CHIEF DEVELOPMENT OFFICER2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 7, 2026 (view filing)4:15 PM ET | Jul 21 | 17 days | Jacob Gary SCHIEF DEVELOPMENT OFFICER | PPurchase | +3.50K | $1.40 | +$4.90K | +3.2%112.4K after | Amended |
| May 19, 2022 (view filing) | May 19 | Same day | Jacob Gary SChief Executive Officer | PPurchaseAmerican Depositary Shares | +12.5K | $4.00 | +$50.0K | New position12.5K after |